Extended surveillance to assess safety of 9-valent human papillomavirus vaccine

• Main Authors: Maria E. Sundaram (Author), Burney A. Kieke (Author), Kayla E. Hanson (Author), Edward A. Belongia (Author), Eric S. Weintraub (Author), Matthew F. Daley (Author), Rulin C. Hechter (Author), Nicola P. Klein (Author), Edwin M. Lewis (Author), Allison L. Naleway (Author), Jennifer C. Nelson (Author), James G. Donahue (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The safety of 9-valent HPV vaccine (9vHPV) has been established with regard to common and uncommon adverse events. However, investigation of rare and severe adverse events requires extended study periods to capture rare outcomes. This observational cohort study investigated the occurrence of three r...